203 related articles for article (PubMed ID: 35868631)
21. Artificial intelligence and synthetic biology approaches for human gut microbiome.
Kumar P; Sinha R; Shukla P
Crit Rev Food Sci Nutr; 2022; 62(8):2103-2121. PubMed ID: 33249867
[TBL] [Abstract][Full Text] [Related]
22. Gut microbiota: an Indicator to Gastrointestinal Tract Diseases.
Patel T; Bhattacharya P; Das S
J Gastrointest Cancer; 2016 Sep; 47(3):232-8. PubMed ID: 27126590
[TBL] [Abstract][Full Text] [Related]
23. Fecal microbiota transplantation prevents Candida albicans from colonizing the gastrointestinal tract.
Matsuo K; Haku A; Bi B; Takahashi H; Kamada N; Yaguchi T; Saijo S; Yoneyama M; Goto Y
Microbiol Immunol; 2019 May; 63(5):155-163. PubMed ID: 30919462
[TBL] [Abstract][Full Text] [Related]
24. Implications of Gut Microbiota in Complex Human Diseases.
Yu D; Meng X; de Vos WM; Wu H; Fang X; Maiti AK
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884466
[TBL] [Abstract][Full Text] [Related]
25. Synthetic Biology Approaches in The Development of Engineered Therapeutic Microbes.
Kang M; Choe D; Kim K; Cho BK; Cho S
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33228099
[TBL] [Abstract][Full Text] [Related]
26. Microbial Metabolites Determine Host Health and the Status of Some Diseases.
Sittipo P; Shim JW; Lee YK
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31653062
[TBL] [Abstract][Full Text] [Related]
27. Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System.
Postler TS; Ghosh S
Cell Metab; 2017 Jul; 26(1):110-130. PubMed ID: 28625867
[TBL] [Abstract][Full Text] [Related]
28. Gastrointestinal worms and bacteria: From association to intervention.
Rooney J; Cantacessi C; Sotillo J; Cortés A
Parasite Immunol; 2023 Apr; 45(4):e12955. PubMed ID: 36300732
[TBL] [Abstract][Full Text] [Related]
29. Molecular mechanistic pathway of colorectal carcinogenesis associated with intestinal microbiota.
Mandal P
Anaerobe; 2018 Feb; 49():63-70. PubMed ID: 29277623
[TBL] [Abstract][Full Text] [Related]
30. Impact of Bacterial Metabolites on Gut Barrier Function and Host Immunity: A Focus on Bacterial Metabolism and Its Relevance for Intestinal Inflammation.
Gasaly N; de Vos P; Hermoso MA
Front Immunol; 2021; 12():658354. PubMed ID: 34122415
[TBL] [Abstract][Full Text] [Related]
31. Engineering the Gut Microbiome for Treatment of Obesity: A Review of Current Understanding and Progress.
Lim YY; Lee YS; Ooi DSQ
Biotechnol J; 2020 Oct; 15(10):e2000013. PubMed ID: 32663372
[TBL] [Abstract][Full Text] [Related]
32. Gastrointestinal Microbiota and Colon Cancer.
Hold GL
Dig Dis; 2016; 34(3):244-50. PubMed ID: 27028619
[TBL] [Abstract][Full Text] [Related]
33. [Advances in host-microbe metabolic axis].
Pi Y; Gao K; Zhu W
Wei Sheng Wu Xue Bao; 2017 Feb; 57(2):161-9. PubMed ID: 29750478
[TBL] [Abstract][Full Text] [Related]
34. Recent advances in gut Microbiota mediated therapeutic targets in inflammatory bowel diseases: Emerging modalities for future pharmacological implications.
Shamoon M; Martin NM; O'Brien CL
Pharmacol Res; 2019 Oct; 148():104344. PubMed ID: 31400403
[TBL] [Abstract][Full Text] [Related]
35. Gut microbes in cerebrovascular diseases: Gut flora imbalance, potential impact mechanisms and promising treatment strategies.
Zou X; Wang L; Xiao L; Wang S; Zhang L
Front Immunol; 2022; 13():975921. PubMed ID: 36389714
[TBL] [Abstract][Full Text] [Related]
36. Engineered microbial systems for advanced drug delivery.
Shen H; Aggarwal N; Wun KS; Lee YS; Hwang IY; Chang MW
Adv Drug Deliv Rev; 2022 Aug; 187():114364. PubMed ID: 35654214
[TBL] [Abstract][Full Text] [Related]
37. Saturated long-chain fatty acid-producing bacteria contribute to enhanced colonic motility in rats.
Zhao L; Huang Y; Lu L; Yang W; Huang T; Lin Z; Lin C; Kwan H; Wong HLX; Chen Y; Sun S; Xie X; Fang X; Yang H; Wang J; Zhu L; Bian Z
Microbiome; 2018 Jun; 6(1):107. PubMed ID: 29903041
[TBL] [Abstract][Full Text] [Related]
38. Microbiomes in physiology: insights into 21st-century global medical challenges.
Shehata E; Parker A; Suzuki T; Swann JR; Suez J; Kroon PA; Day-Walsh P
Exp Physiol; 2022 Apr; 107(4):257-264. PubMed ID: 35081663
[TBL] [Abstract][Full Text] [Related]
39. Engineered Live Biotherapeutics: Progress and Challenges.
Tan Y; Shen J; Si T; Ho CL; Li Y; Dai L
Biotechnol J; 2020 Oct; 15(10):e2000155. PubMed ID: 32770635
[TBL] [Abstract][Full Text] [Related]
40. Microbial community in human gut: a therapeutic prospect and implication in health and diseases.
Dwivedi M; Powali S; Rastogi S; Singh A; Gupta DK
Lett Appl Microbiol; 2021 Nov; 73(5):553-568. PubMed ID: 34365651
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
